Medtide Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	570.09	442.23	336.77	350.84	282.14
Revenue Growth	28.91%	31.31%	-4.01%	24.35%	-
Cost of Revenue	208.48	192.45	157.28	150.05	121.44
Gross Profit	361.61	249.77	179.5	200.79	160.69
Selling, General & Admin	120.16	115.9	71.84	65.72	57.88
Research & Development	29.05	28.75	22.47	20.74	17.34
Operating Expenses	150.6	145.56	94.91	87.59	77.08
Operating Income	211.01	104.21	84.59	113.2	83.61
Interest Expense	-1.24	-1.14	-0.22	-1.28	-4.44
Interest & Investment Income	24.54	13.56	6.92	0.91	0.34
Currency Exchange Gain (Loss)	-13.8	7.31	5.07	11.94	-2.54
Other Non Operating Income (Expenses)	29.92	-48.35	-41.8	-65.53	-20.34
EBT Excluding Unusual Items	250.45	75.59	54.55	59.25	56.63
Gain (Loss) on Sale of Investments	0.37	3.09	7.59	7.92	0.45
Gain (Loss) on Sale of Assets	-0.08	-0.23	-0.16	0.38	32.31
Pretax Income	250.75	78.45	61.98	67.56	89.39
Income Tax Expense	33.37	19.28	13.07	13.58	9.11
Net Income	217.37	59.17	48.91	53.98	80.28
Net Income to Common	217.37	59.17	48.91	53.98	80.28
Net Income Growth	267.35%	21.00%	-9.40%	-32.76%	-
Shares Outstanding (Basic)	134	125	125	100	74
Shares Outstanding (Diluted)	134	128	125	100	92
Shares Change	3.96%	2.74%	24.41%	8.83%	-
EPS (Basic)	1.63	0.47	0.39	0.54	1.09
EPS (Diluted)	1.63	0.38	0.39	0.54	1.06
EPS Growth	332.06%	-3.38%	-27.41%	-49.19%	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	139.02	99.49	33.15	42.65	96.49
Free Cash Flow Per Share	1.04	0.78	0.27	0.42	1.04
Gross Margin	63.43%	56.48%	53.30%	57.23%	56.96%
Operating Margin	37.01%	23.57%	25.12%	32.27%	29.64%
Profit Margin	38.13%	13.38%	14.52%	15.39%	28.45%
Free Cash Flow Margin	24.39%	22.50%	9.84%	12.16%	34.20%
EBITDA	237.98	130.86	110.66	135.56	106.21
EBITDA Margin	41.74%	29.59%	32.86%	38.64%	37.64%
D&A For EBITDA	26.97	26.65	26.07	22.35	22.59
EBIT	211.01	104.21	84.59	113.2	83.61
EBIT Margin	37.01%	23.57%	25.12%	32.27%	29.64%
Effective Tax Rate	13.31%	24.57%	21.09%	20.10%	10.20%